Outcomes of endovascular interventions for TASC II B and C femoropopliteal lesions

Journal of Vascular Surgery

Volumn 48, Issue 3, 2008, Pages 627-633

  Baril, Donald T ^a   Marone, Luke K ^a   Kim, Justine ^a   Go, Michael R ^a   Chaer, Rabih A ^a   Rhee, Robert Y ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY OCCLUSION; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOVASCULAR SURGERY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; POPLITEAL ARTERY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RESTENOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ANKLE; ARTERIAL OCCLUSIVE DISEASES; BLOOD PRESSURE; BRACHIAL ARTERY; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; POPLITEAL ARTERY; RECURRENCE; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT FAILURE; VASCULAR PATENCY;

EID: 49749108564     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.04.059     Document Type: Article

References (31)

1. Bhatt D.L., Steg P.G., Ohman E.M., Hirsch A.T., Ikeda Y., Mas J.L., et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 295 (2006) 180-189
2. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001) 1317-1324
3. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
4. Crowther R.G., Spinks W.L., Leicht A.S., Sangla K., Quigley F., and Golledge J. Effects of a long-term exercise program on lower limb mobility, physiological responses, walking performance, and physical activity levels in patients with peripheral arterial disease. J Vasc Surg 47 (2008) 303-309
5. Robless P., Mikhailidis D., and Stansby G. Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev (2008) CD003748
6. Casey K., Tonnessen B.H., Sternbergh III W.C., and Money S.R. Medical management of intermittent claudication. Vasc Endovascular Surg 38 (2004) 391-399
7. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., and TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 Suppl S (2007) S5-S67
8. Ferreira M., Lanziotti L., Monteiro M., Abuhadba G., Capotorto L.F., Nolte L., et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 34 (2007) 702-708
9. Krankenberg H., Schlüter M., Steinkamp H.J., Bürgelin K., Scheinert D., Schulte K.L., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116 (2007) 285-292
10. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
11. Akopian G., and Katz S.G. Peripheral angioplasty with same-day discharge in patients with intermittent claudication. J Vasc Surg 44 (2006) 115-118
12. Nolan B., Finlayson S., Tosteson A., Powell R., and Cronenwett J. The treatment of disabling intermittent claudication in patients with superficial femoral artery occlusive disease-decision analysis. J Vasc Surg 45 (2007) 1179-1184
13. Clark T.W., Groffsky J.L., and Soulen M.C. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 12 (2001) 923-933
14. Becquemin J.P., Cavillon A., and Haiduc F. Surgical transluminal femoropopliteal angioplasty: multivariate analysis outcome. J Vasc Surg 19 (1994) 495-502
15. Conrad M.F., Cambria R.P., Stone D.H., Brewster D.C., Kwolek C.J., Watkins M.T., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44 (2006) 762-769
16. Kudo T., Chandra F.A., Kwun W.H., Haas B.T., and Ahn S.S. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs open bypass surgery. J Vasc Surg 44 (2006) 304-313
17. Surowiec S.M., Davies M.G., Eberly S.W., Rhodes J.M., Illig K.A., Shortell C.K., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005) 269-278
18. Devine C., McCollum C., and North West Femoro-Popliteal Trial Participants. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial. J Vasc Surg 40 (2004) 924-931
19. Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., and Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 45 (2007) 10-16
20. Klinkert P., Post P.N., Breslau P.J., and van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg 27 (2004) 357-362
21. Burger D.H., Kappetein A.P., Van Bockel J.H., and Breslau P.J. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting. J Vasc Surg 32 (2000) 278-283
22. Pereira C.E., Albers M., Romiti M., Brochado-Neto F.C., and Pereira C.A. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006) 510-517
23. Galaria I.I., Surowiec S.M., Rhodes J.M., Shortell C.K., Illig K.A., and Davies M.G. Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg 19 (2005) 787-792
24. Molloy K.J., Nasim A., London N.J., Naylor A.R., Bell P.R., Fishwick G., et al. Percutaneous transluminal angioplasty in the treatment of critical limb ischemia. J Endovasc Ther 10 (2003) 298-303
25. Bakken A.M., Palchik E., Hart J.P., Rhodes J.M., Saad W.E., and Davies M.G. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 46 (2007) 946-958
26. Derubertis B.G., Pierce M., Ryer E.J., Trocciola S., Kent K.C., and Faries P.L. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 47 (2008) 101-108
27. Jämsén T.S., Manninen H.I., Tulla H.E., Jaakkola P.A., and Matsi P.J. Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment. J Vasc Surg 37 (2003) 808-815
28. Aung P.P., Maxwell H.G., Jepson R.G., Price J.F., and Leng G.C. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev (2007) CD000123
29. Abbruzzese T.A., Havens J., Belkin M., Donaldson M.C., Whittemore A.D., Liao J.K., et al. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2004) 1178-1185
30. Muradin G.S., Bosch J.L., Stijnen T., and Hunink M.G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology 221 (2001) 137-145
31. Mwipatayi B.P., Hockings A., Hofmann M., Garbowski M., and Sieunarine K. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. J Vasc Surg 47 (2008) 461-469